0000899243-23-004800.txt : 20230213 0000899243-23-004800.hdr.sgml : 20230213 20230213173531 ACCESSION NUMBER: 0000899243-23-004800 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAPORTE KATHLEEN CENTRAL INDEX KEY: 0001196201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 23620297 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-09 0 0001785173 89bio, Inc. ETNB 0001196201 LAPORTE KATHLEEN C/O 89BIO, INC., 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 1 0 0 0 Stock Option (Right to Buy) 14.70 2023-02-09 4 A 0 27400 0.00 A 2033-02-09 Common Stock 27400 27400 D This option represents a right to purchase a total of 27,400 shares of the Issuer's Common Stock, which will vest in full on February 9, 2024, subject to the Reporting Person's continued service to the Issuer through such date. /s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte 2023-02-13